Publicacións nas que colabora con Elena Gonzalez-Rey (51)

2019

  1. Bone marrow mesenchymal stem/stromal cells from risk-stratified acute myeloid leukemia patients are anti-inflammatory in in vivo preclinical models of hematopoietic reconstitution and severe colitis

    Haematologica, Vol. 104, Núm. 2, pp. e54-e58

2009

  1. Adipose-Derived Mesenchymal Stem Cells Alleviate Experimental Colitis by Inhibiting Inflammatory and Autoimmune Responses

    Gastroenterology, Vol. 136, Núm. 3, pp. 978-989

  2. Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis

    Gut, Vol. 58, Núm. 7, pp. 929-939

  3. Neuropeptides kill African trypanosomes by targeting intracellular compartments and inducing autophagic-like cell death

    Cell Death and Differentiation, Vol. 16, Núm. 3, pp. 406-416

  4. Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells

    Arthritis and Rheumatism, Vol. 60, Núm. 4, pp. 1006-1019

2008

  1. Emergence of cortistatin as a new immunomodulatory factor with therapeutic potential in immune disorders

    Molecular and Cellular Endocrinology, Vol. 286, Núm. 1-2, pp. 135-140

  2. Genetic association of vasoactive intestinal peptide receptor with rheumatoid arthritis: Altered expression and signal in immune cells

    Arthritis and Rheumatism, Vol. 58, Núm. 4, pp. 1010-1019

  3. Ghrelin protects against experimental sepsis by inhibiting high-mobility group box 1 release and by killing bacteria

    Journal of Immunology, Vol. 180, Núm. 12, pp. 8369-8377

  4. In vivo delivery of lentiviral vectors expressing vasoactive intestinal peptide complementary DNA as gene therapy for collagen-induced arthritis

    Arthritis and Rheumatism, Vol. 58, Núm. 4, pp. 1026-1037

  5. Vasoactive intestinal peptide inhibits cycloxygenase-2 expression in activated macrophages, microglia, and dendritic cells

    Brain, Behavior, and Immunity, Vol. 22, Núm. 1, pp. 35-41

  6. Vasoactive intestinal peptide protects against β-amyloid-induced neurodegeneration by inhibiting microglia activation at multiple levels

    GLIA, Vol. 56, Núm. 10, pp. 1091-1103

2007

  1. Adrenomedullin protects from experimental arthritis by down-regulating inflammation and Th1 response and inducing regulatory T cells

    American Journal of Pathology, Vol. 170, Núm. 1, pp. 263-271

  2. Anti-inflammatory neuropeptide receptors: new therapeutic targets for immune disorders?

    Trends in Pharmacological Sciences, Vol. 28, Núm. 9, pp. 482-491

  3. Emerging roles of vasoactive intestinal peptide: A new approach for autoimmune therapy

    Annals of the Rheumatic Diseases

  4. Regulation of immune tolerance by anti-inflammatory neuropeptides

    Nature Reviews Immunology, Vol. 7, Núm. 1, pp. 52-63

  5. Therapeutic effect of a poly(ADP-ribose) polymerase-1 inhibitor on experimental arthritis by downregulating inflammation and Th1 response

    PLoS ONE, Vol. 2, Núm. 10

  6. Therapeutic effect of cortistatin on experimental arthritis by downregulating inflammatory and Th1 responses

    Annals of the Rheumatic Diseases, Vol. 66, Núm. 5, pp. 582-588

  7. Therapeutic effect of urocortin on collagen-induced arthritis by down-regulation of inflammatory and Th1 responses and induction of regulatory T cells

    Arthritis and Rheumatism, Vol. 56, Núm. 2, pp. 531-543

  8. Therapeutical approaches of vasoactive intestinal peptide as a pleiotropic immunomodulator

    Current Pharmaceutical Design, Vol. 13, Núm. 11, pp. 1113-1139

  9. Tuning immune tolerance with vasoactive intestinal peptide: A new therapeutic approach for immune disorders

    Peptides, Vol. 28, Núm. 9, pp. 1833-1846